Clinical Trial Update: Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism [Phase 4]

View source ↗

Summary

Phase 4 trial comparing finerenone and spironolactone for primary aldosteronism and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Hypertension

Drugs mentioned

• Finerenone (finerenone)
• Spironolactone (spironolactone)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Primary Aldosteronism, Hypertension | Phase 4 | Status: UNKNOWN